Innovative Cellular Therapeutics Announces FDA Clearance of IND for its Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy
https://www.ictbio.com/wp-content/uploads/2019/06/ict-image.jpg
3000
2250
Innovative Cellular Therapeutics
https://www.ictbio.com/wp-content/uploads/2019/06/ict-image.jpg
Innovative Cellular Therapeutics Announces FDA Clearance of IND for its Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy
ROCKVILLE, Md., December 4, 2019 — Innovative Cel…